BRCA2 and ovarian cancer: A high risk of malignant ovarian tumors is observed in women over the age of 49 with a burdened hereditary history (mutations of the BRCA1 and BRCA2 genes, Lynch syndrome, etc.)and after ovarian hyperstimulation, when using hormone replacement therapy, endometriosis, or obesity.